This is generally consistent with multiple previous studies and meta-analyses.5, 30 In the TRD patients, ketamine decreased serum levels of IL-6 and IL-1α 4 h after the infusion, but levels had returned to baseline by 24 h after the infusion. Here, IL6 is linked to treatment resistant depression.